日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial

FOLFIRI联合度伐利尤单抗(加或不加曲美利木单抗)二线治疗晚期胃癌或胃食管交界处腺癌:PRODIGE 59-FFCD 1707-DURIGAST随机临床试验

Tougeron, David; Dahan, Laetitia; Evesque, Ludovic; Le Malicot, Karine; El Hajbi, Farid; Aparicio, Thomas; Bouché, Olivier; Bonichon Lamichhane, Nathalie; Chibaudel, Benoist; Angelergues, Antoine; Bodere, Anaïs; Phelip, Jean-Marc; Mabro, May; Kaluzinski, Laure; Petorin, Caroline; Breysacher, Gilles; Rinaldi, Yves; Zaanan, Aziz; Smith, Denis; Gouttebel, Marie-Claude; Perret, Clément; Etchepare, Nicolas; Emile, Jean-François; Sanfourche, Ivan; Di Fiore, Frédéric; Lepage, Côme; Artru, Pascal; Louvet, Christophe

Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy

新辅助化疗下卵巢癌的空间分布及肿瘤微环境演变

Yaniz-Galende, Elisa; Zeng, Qinghe; Bejar-Grau, Juan F; Klein, Christophe; Blanc-Durand, Felix; Le Formal, Audrey; Pujade-Lauraine, Eric; Chardin, Laure; Edmond, Elodie; Marty, Virginie; Ray-Coquard, Isabelle; Joly, Florence; Ferron, Gwenael; Pautier, Patricia; Berton-Rigaud, Dominique; Lortholary, Alain; Dohollou, Nadine; Desauw, Christophe; Fabbro, Michel; Malaurie, Emmanuelle; Bonichon-Lamaichhane, Nathalie; Bello Roufai, Diana; Gantzer, Justine; Rouleau, Etienne; Genestie, Catherine; Leary, Alexandra

Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data

抗雄激素治疗雄激素受体阳性三阴性转移性乳腺癌的疗效:真实世界数据

Rhanine, Yasmine; Bonnefoi, Hervé; Goncalves, Anthony; Debled, Marc; Le Moulec, Sylvestre; Bonichon, Nathalie; Macgrogan, Gaetan; Arnedos, Monica; Dubroca-Dehez, Bénédicte; Grellety, Thomas

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

根据 TOP2A 方案,对 HER2 阳性乳腺癌患者进行新辅助蒽环类药物化疗(5-FEC 方案)或不含蒽环类药物的化疗(多西他赛/卡铂方案)联合曲妥珠单抗和帕妥珠单抗治疗:一项多中心、开放标签、非随机 II 期试验

Ginzac, Angeline; Molnar, Ioana; Durando, Xavier; Motte Rouge, Thibault De La; Petit, Thierry; D'hondt, Véronique; Campone, Mario; Bonichon-Lamichhane, Nathalie; Venat Bouvet, Laurence; Levy, Christelle; Augereau, Paule; Pistilli, Barbara; Arsene, Olivier; Jouannaud, Christelle; Nguyen, Suzanne; Cayre, Anne; Tixier, Lucie; Mahier Ait Oukhatar, Céline; Nabholtz, Jean-Marc; Penault-Llorca, Frédérique; Mouret-Reynier, Marie-Ange

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

围手术期西妥昔单抗联合顺铂和5-氟尿嘧啶治疗食管腺癌:一项II期研究

Gronnier, Caroline; Mariette, Christophe; Lepage, Come; Monterymard, Carole; Jary, Marine; Ferru, Aurélie; Baconnier, Mathieu; Adhoute, Xavier; Tavan, David; Perrier, Hervé; Guerin-Meyer, Véronique; Lecaille, Cédric; Bonichon-Lamichhane, Nathalie; Pillon, Didier; Cojocarasu, Oana; Egreteau, Joëlle; D'journo, Xavier Benoit; Dahan, Laétitia; Locher, Christophe; Texereau, Patrick; Collet, Denis; Michel, Pierre; Ben Abdelghani, Meher; Guimbaud, Rosine; Muller, Marie; Bouché, Olivier; Piessen, Guillaume

Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer

利用 (18)F-FDG PET/CT 预测肿瘤反应和二次手术预后:来自 GINECO CHIVA II 期临床试验(新辅助化疗联合尼达尼布治疗 FIGO IIIc-IV 期卵巢癌)的启示

Aide, Nicolas; Fauchille, Pauline; Coquan, Elodie; Ferron, Gwenael; Combe, Pierre; Meunier, Jérome; Alexandre, Jerôme; Berton, Dominique; Leary, Alexandra; De Rauglaudre, Gaétan; Bonichon, Nathalie; Pujade Lauraine, Eric; Joly, Florence

Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment

化疗后 TSP1 和 CD47 对衰老逃逸的调节

Jordan Guillon, Coralie Petit, Marie Moreau, Bertrand Toutain, Cécile Henry, Henry Roché, Nathalie Bonichon-Lamichhane, Jean Paul Salmon, Jérôme Lemonnier, Mario Campone, Véronique Verrièle, Eric Lelièvre, Catherine Guette, Olivier Coqueret

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer

索拉非尼治疗放射性碘难治性甲状腺癌患者的安全性和耐受性

Worden, Francis; Fassnacht, Martin; Shi, Yuankai; Hadjieva, Tatiana; Bonichon, Françoise; Gao, Ming; Fugazzola, Laura; Ando, Yuichi; Hasegawa, Yasuhisa; Park, Do Joon; Shong, Young Kee; Smit, Johannes W A; Chung, John; Kappeler, Christian; Meinhardt, Gerold; Schlumberger, Martin; Brose, Marcia S

Identification of a recurrent STRN/ALK fusion in thyroid carcinomas

甲状腺癌中复发性STRN/ALK融合基因的鉴定

Pérot, Gaëlle; Soubeyran, Isabelle; Ribeiro, Agnès; Bonhomme, Benjamin; Savagner, Frédérique; Boutet-Bouzamondo, Nathalie; Hostein, Isabelle; Bonichon, Françoise; Godbert, Yann; Chibon, Frédéric